Daiwa Securities Group Inc. Reduces Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Daiwa Securities Group Inc. lessened its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 6.1% during the 4th quarter, Holdings Channel reports. The institutional investor owned 62,534 shares of the medical equipment provider’s stock after selling 4,039 shares during the quarter. Daiwa Securities Group Inc.’s holdings in Intuitive Surgical were worth $21,096,000 at the end of the most recent quarter.

Several other institutional investors have also recently made changes to their positions in ISRG. OFI Invest Asset Management acquired a new position in Intuitive Surgical in the third quarter valued at about $25,000. Baystate Wealth Management LLC lifted its holdings in shares of Intuitive Surgical by 150.0% in the 4th quarter. Baystate Wealth Management LLC now owns 75 shares of the medical equipment provider’s stock worth $25,000 after acquiring an additional 45 shares during the last quarter. Headinvest LLC purchased a new position in shares of Intuitive Surgical during the 3rd quarter worth approximately $28,000. Stone House Investment Management LLC increased its holdings in Intuitive Surgical by 100.0% in the 3rd quarter. Stone House Investment Management LLC now owns 100 shares of the medical equipment provider’s stock valued at $29,000 after purchasing an additional 50 shares during the last quarter. Finally, Householder Group Estate & Retirement Specialist LLC purchased a new stake in Intuitive Surgical in the third quarter valued at approximately $30,000. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Stock Down 1.2 %

Shares of ISRG opened at $374.17 on Thursday. The company has a market capitalization of $132.62 billion, a price-to-earnings ratio of 74.39, a price-to-earnings-growth ratio of 5.88 and a beta of 1.36. Intuitive Surgical, Inc. has a 52-week low of $254.85 and a 52-week high of $403.76. The stock has a 50 day moving average price of $387.56 and a 200 day moving average price of $342.39.

Intuitive Surgical (NASDAQ:ISRG) last issued its earnings results on Tuesday, January 23rd. The medical equipment provider reported $1.60 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.48 by $0.12. Intuitive Surgical had a net margin of 25.24% and a return on equity of 13.11%. The business had revenue of $1.93 billion during the quarter, compared to analysts’ expectations of $1.89 billion. During the same quarter in the prior year, the business posted $0.91 EPS. The company’s revenue for the quarter was up 16.6% on a year-over-year basis. On average, equities analysts anticipate that Intuitive Surgical, Inc. will post 4.93 EPS for the current fiscal year.

Insider Buying and Selling at Intuitive Surgical

In other news, VP Marshall Mohr sold 108,790 shares of Intuitive Surgical stock in a transaction dated Wednesday, February 28th. The stock was sold at an average price of $385.08, for a total transaction of $41,892,853.20. Following the sale, the vice president now owns 26,877 shares in the company, valued at $10,349,795.16. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In other news, VP Marshall Mohr sold 108,790 shares of the stock in a transaction that occurred on Wednesday, February 28th. The stock was sold at an average price of $385.08, for a total value of $41,892,853.20. Following the completion of the sale, the vice president now directly owns 26,877 shares of the company’s stock, valued at $10,349,795.16. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Alan J. Levy sold 2,000 shares of Intuitive Surgical stock in a transaction on Friday, January 26th. The shares were sold at an average price of $370.20, for a total transaction of $740,400.00. Following the completion of the transaction, the director now directly owns 25,319 shares in the company, valued at $9,373,093.80. The disclosure for this sale can be found here. Insiders sold 248,418 shares of company stock worth $95,927,097 over the last 90 days. Corporate insiders own 0.90% of the company’s stock.

Analyst Ratings Changes

ISRG has been the subject of a number of research reports. Citigroup lifted their price objective on Intuitive Surgical from $428.00 to $462.00 and gave the company a “buy” rating in a research note on Wednesday, April 3rd. Piper Sandler boosted their price target on shares of Intuitive Surgical from $325.00 to $425.00 and gave the stock an “overweight” rating in a research note on Wednesday, January 24th. Barclays raised their price objective on shares of Intuitive Surgical from $385.00 to $430.00 and gave the company an “overweight” rating in a research note on Thursday, January 25th. Truist Financial upped their target price on shares of Intuitive Surgical from $390.00 to $435.00 and gave the stock a “buy” rating in a research note on Wednesday, January 24th. Finally, Mizuho increased their target price on shares of Intuitive Surgical from $350.00 to $390.00 and gave the stock a “neutral” rating in a report on Thursday, January 25th. Five investment analysts have rated the stock with a hold rating and fourteen have given a buy rating to the stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $375.70.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.